Press Releases

BIO’s Mission is to be the champion for biotechnology. We advocate for policies that will enable the realization of biotechnology’s promise for providing breakthrough products to cure disease, protecting against bio-terrorism, feeding the hungry, and cleaning our environment.

May 29 2014

Delaware Governor Markell signed legislation designed to create a pathway for the substitution...

March 25 2014

The Biotechnology Industry Organization (BIO) and the Indiana Health Industry Forum (IHIF)...

January 22 2014

BIO and WBBA commend the Washington State House and Senate for continuing to advance...

November 13 2013

The Pennsylvania Senate Public Health and Welfare Committee approved Senate Bill 405, which...

September 5 2013

Jim Greenwood, President and CEO of BIO, issued the following statement on the California...

August 1 2013

BIO Jobs is your online resource for biotechnology employment opportunities.

June 10 2013

BIO and Delaware Biocommend the State Senate for introducing legislation designed to ...

June 7 2013

Oregon Governor John Kitzhaber signed legislation on Thursday, June 6 designed to address the...

June 5 2013

House Bill 365, signed by Governor Rick Scott, contains four of BIO’s five principles on...

April 3 2013

The Biotechnology Industry Organization (BIO) and ...

March 21 2013

In statehouses around the country, lawmakers are beginning to address the complexities of...

February 11 2013

An inside look at two cases facing the Supreme Court of the United States:...

June 14 2012

Support Of Industry Underscores Pro-Business Commitment

March 2 2012

The Biotechnology Industry Organization (BIO) announced today that it has integrated its...

February 15 2012

The bill will modernize the FDA and accelerate patient access to cures and new treatments.

January 17 2012

Bittenbender will spearhead BIO’s engagement in and support of state-level legislative...

June 6 2011

The United States Supreme Court issued it's opinion on the appeal of Stanford University...

February 14 2011

The study is expected to inform and improve communications between biotech executives,...

February 8 2011

Since 1995, Pellerito has served as an industry member representative of BIO’s Federal...

June 30 1999

 The American Hospital Association and BIO have signed a memorandum of understanding to...

May 8 2013
BIO  urges Florida Governor Scott to sign House Bill 365 – a bill related to the substitution of biologic and biosimilar medicines – which recently passed out of the Legislature.
February 1 2013
BIO supports passage of Florida House Bill 365, which provides requirements for pharmacist to dispense substitute biological products that are determined to be interchangeable for prescribed biological product.
January 24 2013
To ensure transparency and communication between patients and their treatment teams, BIO believes that certain safeguards should guide substitution policies for interchangeable biologics under state law as well.
January 24 2013
The policies outlined in Senate Bill 2190 align with all five of BIO’s Principles on Biologic Product Substitution and we therefore support its passage.
January 24 2013
BIO opposes the proposal to subject certain cancer therapies to prior authorization measures under Senate Bill 2066.
July 11 2014
Today's oral arguments offered an important opportunity to educate stakeholders within Alameda County and all of California about the unnecessary and burdensome impacts that will result if this proposed take back program is allowed to stand.
May 29 2014
Delaware Governor Markell signed legislation designed to create a pathway for the substitution of interchangeable biologic medicines.
March 25 2014
The Biotechnology Industry Organization (BIO) and the Indiana Health Industry Forum (IHIF) commend Indiana Governor Mike Pence for signing legislation today designed to create a pathway for the substitution of interchangeable biologic medicines.
January 22 2014
BIO and WBBA commend the Washington State House and Senate for continuing to advance legislation designed to create a pathway for the substitution of interchangeable biologic medicines.
November 13 2013
The Pennsylvania Senate Public Health and Welfare Committee approved Senate Bill 405, which would require a pharmacist to notify the patient and, within 72 hours, the patient’s physician of any biologic product substitution.